Day One Biopharmaceuticals, Inc.DAWNNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank4
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Latest
-143.74%
↓ 597% vs avg
Percentile
P4
Near historical low
Streak
1 qtr
Consecutive declineDecelerating
Average
-20.62%
Historical baseline
PeriodValue
Q4 2025-143.74%
Q3 202576.60%
Q2 202557.95%
Q1 2025-96.60%
Q4 2024-159.13%
Q3 2024203.31%
Q2 20241.21%
Q1 2024-20.20%
Q4 2023-11.62%
Q3 202312.65%
Q2 2023-63.29%
Q1 202326.41%
Q4 2022-52.11%
Q3 202222.07%
Q2 2022-38.14%
Q1 2022-63.74%
Q4 2021-7.76%
Q3 20218.84%
Q2 2021-37.60%
Q1 2021-64.08%
Q4 2020-65.96%
Q3 2020-89.51%
Q2 20209.45%
Q1 20200.00%